✦ LIBER ✦

Rescue of death receptor and mitochondrial apoptosis signaling in resistant human NSCLC in vivo

✍ Scribed by Stella Okouoyo; Kerstin Herzer; Esat Ucur; Jürgen Mattern; Peter H. Krammer; Klaus-Michael Debatin; Ingrid Herr

Publisher: John Wiley and Sons
Year: 2003
Tongue: French
Weight: 1004 KB
Volume: 108
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.11585

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Non small cell lung carcinoma (NSCLC) is a highly lethal malignancy that often becomes resistant to chemotherapy. To determine whether alterations in apoptotic signaling might contribute to such resistance, we established in vitro and in vivo models for sensitive and resistant human NSCLC. We found that resistance is due to multiple defects found in expression of CD95‐L, CD95 and members of the Bcl‐2 and IAP family, as well as caspase‐8, ‐9 and ‐3 as examined by immunohistochemistry, Western blot analysis, gene array analysis and functional assays. Failure to activate death receptor, as well as mitochondrial apoptosis signaling, points to a central role of caspases. To restore apoptosis signaling we transfected NSCLC xenografts on nude mice with caspase‐8 and ‐9. This treatment strongly induced apoptosis per se and sensitized the tumors to cisplatin‐induced cell death. Thus, these findings indicate that re‐expression of caspases might be an effective strategy to restore sensitivity for chemotherapy in NSCLC in vivo. © 2003 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Ionizing radiation enhances tumor necros

Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells

✍ Takeshi Hori; Takashi Kondo; Masahiko Kanamori; Yoshiaki Tabuchi; Ryohei Ogawa; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 228 KB 👁 1 views

## Abstract Despite improvements in chemotherapy and surgery in the treatment of osteosarcoma (OS), satisfactory results are still difficult to achieve. Novel therapeutic modalities need to be developed for osteosarcoma treatment. The combined effects of tumor necrosis factor‐related apoptosis‐indu

Distinct mechanisms for rescue from apop

Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signaling through CD40 and interleukin-4 receptor: role for inhibition of an early response gene, Berg36

✍ Zhi-Qiang Ning; John D. Norton; Jin Li; John J. Murphy 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 945 KB

Direct inhibition of interleukin-2 recep

Direct inhibition of interleukin-2 receptor α-mediated signaling pathway induces G1 arrest and apoptosis in human head-and-neck cancer cells

✍ Deborah J. Kuhn; Q. Ping Dou 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB

## Abstract Overexpression of the interleukin‐2 receptor (IL‐2R) α chain in tumor cells is associated with tumor progression and a poor patient prognosis. IL‐2Rα is responsible for the high affinity binding of the receptor to IL‐2, leading to activation of several proliferative and anti‐apoptotic i

Naringenin up-regulates the expression o

Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells

✍ Cheng-Yun Jin; Cheol Park; Hye Jin Hwang; Gi-Young Kim; Byung Tae Choi; Wun-Jae 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB

While TRAIL is relatively non-toxic to normal cells, it can selectively induce apoptosis in many types of transformed cells. Nevertheless, some non-small cell lung cancer (NSCLC) cells are particularly resistant to the effects of TRAIL. Here, we report that in combination with naringenin exposure to